Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 163,547,408
  • Shares Outstanding, K 1,768,845
  • Annual Sales, $ 31,904 M
  • Annual Income, $ 3,687 M
  • 60-Month Beta 0.97
  • Price/Sales 5.15
  • Price/Cash Flow 18.63
  • Price/Book 5.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.42
  • Number of Estimates 9
  • High Estimate 0.50
  • Low Estimate 0.29
  • Prior Year 0.82
  • Growth Rate Est. (year over year) -48.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
86.16 +7.45%
on 06/25/20
93.97 -1.48%
on 07/06/20
+0.02 (+0.02%)
since 06/08/20
3-Month
82.95 +11.61%
on 04/09/20
100.00 -7.42%
on 04/20/20
+7.63 (+8.98%)
since 04/08/20
52-Week
61.61 +50.27%
on 03/23/20
100.00 -7.42%
on 04/20/20
+7.49 (+8.80%)
since 07/08/19

Most Recent Stories

More News
Next Resistance Level for Abbott Labs (ABT) is $93.96

Shares of Abbott Labs (NYSE:ABT) have bullishly opened above the pivot of $92.65 today and have reached the first resistance level of $93.21. Investors may be interested in a cross of the next upside...

ABT : 92.58 (+0.13%)
LabCorp Launches At-Home Coronavirus Test Collection Kit

LabCorp (LH) claims this to be the first digital COVID-19 service that physicians can use to remotely diagnose patients before any surgery or procedure.

DGX : 117.92 (+0.52%)
QGEN : 43.57 (+0.88%)
ABT : 92.58 (+0.13%)
LH : 174.46 (+0.77%)
$10+ Billion Worldwide Cell Counting Industry to 2025 - Featuring Abbott Laboratories, Perkinelmer & Agilent Technologies Among Others

, /PRNewswire/ -- The report has been added to offering.

ABT : 92.58 (+0.13%)
A : 89.54 (+0.37%)
Danaher Shares Gain 26% in 3 Months: What's Driving the Rally?

Danaher (DHR), with 26% growth in shares in the past three months, benefits from healthy demand for its products and synergistic benefits from acquired assets despite the pandemic-led woes.

GE : 6.86 (+1.48%)
ABT : 92.58 (+0.13%)
DHR : 184.42 (+1.31%)
TMO : 386.63 (+1.68%)
The Zacks Analyst Blog Highlights: Abbott Laboratories, Zoom Video Communications, Amazon.com and NVIDIA

The Zacks Analyst Blog Highlights: Abbott Laboratories, Zoom Video Communications, Amazon.com and NVIDIA

NVDA : 408.64 (+3.49%)
AMZN : 3,081.11 (+2.70%)
ABT : 92.58 (+0.13%)
ZM : 266.32 (+1.61%)
EHO360 Expands Its Executive Leadership Team With an Emphasis on Hospice

, /PRNewswire/ --  is an experienced national with a deep understanding of the hospice system with hospice provider clients across the country. To expand its reach within the hospice sector, EHO360...

ABT : 92.58 (+0.13%)
Wearable Devices Offer Patients More Freedom With Smartphone Implementation

, /PRNewswire/ -- Wearable devices have now become one of the fastest developing segments of the technology and medical technology industries. Wearable devices were designed to track real time data on...

ABT : 92.58 (+0.13%)
MDT : 91.61 (-0.07%)
NMRD : 8.02 (+2.56%)
TNDM : 103.81 (+1.79%)
Pomerantz Law Firm Announces the Filing of a Class Action against Co-Diagnostics, Inc. and Certain Officers - CODX

Pomerantz LLP announces that a class action lawsuit has been filed against Co-Diagnostics, Inc. ("Co-Diagnostics" or the "Company")(NASDAQ: CODX) and certain of its officers. The class action, filed in...

CODX : 18.97 (+5.74%)
ABT : 92.58 (+0.13%)
SmarTrend Watching for Potential Pullback in Shares of Abbott Labs After 1.31% Gain

Abbott Labs (NYSE:ABT) traded in a range yesterday that spanned from a low of $92.73 to a high of $93.97. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $93.06...

ABT : 92.58 (+0.13%)
Abbott Receives FDA Approval for New Heart Rhythm Devices Featuring Bluetooth Connectivity and Continuous Remote Monitoring

ABBOTT PARK, Ill., /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation Gallant™ implantable cardioverter defibrillator...

ABT : 92.58 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ABT with:

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Key Turning Points

2nd Resistance Point 94.75
1st Resistance Point 93.67
Last Price 92.58
1st Support Level 91.50
2nd Support Level 90.41

See More

52-Week High 100.00
Last Price 92.58
Fibonacci 61.8% 85.34
Fibonacci 50% 80.81
Fibonacci 38.2% 76.27
52-Week Low 61.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar